{
    "Trade/Device Name(s)": [
        "DIACHEX* DETERMINE Blood Glucose Monitoring System",
        "DIACHEX* INFINITY Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Tyson Bioresearch, Inc.",
    "510(k) Number": "K073492",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062829"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "March 10, 2008",
    "Summary Letter Received Date": "March 11, 2008",
    "Submission Date": "December 12, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "DIACHEX* DETERMINE meter",
        "DIACHEX* INFINITY meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric biosensor",
        "Glucose oxidase reaction"
    ],
    "Methodologies": [
        "In vitro quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for DIACHEX* DETERMINE and DIACHEX* INFINITY Blood Glucose Monitoring Systems for quantitative glucose measurement using electrochemical biosensor technology.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, and forearm, for over-the-counter home use by persons with diabetes or clinical use by healthcare professionals, as an aid in monitoring diabetes control; not for diagnosis or screening of diabetes or for neonatal testing.",
    "fda_folder": "Clinical Chemistry"
}